Money manager Martin Sass says he found a health-care stock nearly immune from bad quarters: McKesson, the U.S. drug wholesaler that's taking over German company Celesio.
"I've owned them for three years and they have beaten and raised every quarter we've owned them," Sass said on CNBC's "Squawk Box." "We felt they'll do it again."
Sass, the CEO of MD Sass, said McKesson has joined an oligopoly of companies that control the vast majority of the drug distribution market. The growing popularity of generic drugs will help boost profits as well, he told CNBC.
McKesson did not beat expectations last quarter.
As part of "Squawk Box's running Platinum Portfolio challenge, Sass also choose airplane leasing company AerCap and local broadcaster NexStar Broadcasting as stocks that are likely to see strong growth. Miller owns shares of all three stocks.